Advanced renal cell carcinoma: immunotherapy and tyrosine kinase inhibitor effective in the long term
11 June, 2024
0 Comments
1 category
Chicago – First-generation angiogenic tyrosine kinase inhibitors have made significant progress in the treatment of advanced renal cell carcinoma for the first time. With immune checkpoint inhibitors in combination with next-generation angiogenesis inhibitors,… [weiter lesen]